We are live on !
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$307M
Turnover
5.13%
1-Year Est. Return
22.88%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+22.88%
3 Year Est. Return
+98.56%
5 Year Est. Return
+145.32%
10 Year Est. Return
+437.4%
AUM
$119M
AUM Growth
+$2.79M
(+2.4%)
Cap. Flow
-$316K
Cap. Flow % of AUM
Cap. Flow %
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
52.72%
Holding
47
New
1
Increased
–
Reduced
1
Closed
–
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BP
BP
|
+$184K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philips
PHG
|
+$47K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.94% |
| 2 | Financials | 20.62% |
| 3 | Technology | 19.21% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Staples | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Progressive
PGR
$137B
| $20.5M | 17.18% |
610,608
| – | – |
2013 Q2
12 quarters
|
|
2
Stryker
SYK
$118B
| $9.43M | 7.92% |
78,700
| – | – |
2013 Q2
12 quarters
|
|
3
GE Aerospace
GE
$344B
| $5.52M | 4.63% |
36,553
| – | – |
2013 Q2
12 quarters
|
|
4
Johnson & Johnson
JNJ
$688B
| $5.39M | 4.53% |
44,438
| – | – |
2013 Q2
12 quarters
|
|
5
Bristol-Myers Squibb
BMY
$130B
| $4.41M | 3.71% |
60,020
| – | – |
2013 Q2
12 quarters
|
|
6
DELISTED
Du Pont De Nemours E I
DD
| $4.28M | 3.59% |
65,970
| – | – |
2013 Q2
12 quarters
|
|
7
Unilever
UL
$143B
| $3.76M | 3.16% |
69,724
| – | – |
2013 Q2
12 quarters
|
|
8
Microsoft
MSFT
$3.89T
| $3.26M | 2.73% |
63,600
| – | – |
2013 Q2
12 quarters
|
|
9
Intel
INTC
$317B
| $3.17M | 2.66% |
96,660
| – | – |
2013 Q2
12 quarters
|
|
10
IBM
IBM
$234B
| $3.09M | 2.6% |
21,301
| – | – |
2013 Q2
12 quarters
|
|
11
Merck
MRK
$364B
| $3.05M | 2.56% |
55,439
| – | – |
2013 Q2
12 quarters
|
|
12
Pfizer
PFE
$165B
| $2.94M | 2.47% |
88,123
| – | – |
2013 Q2
12 quarters
|
|
13
Emerson Electric
EMR
$91.3B
| $2.59M | 2.17% |
49,600
| – | – |
2013 Q2
12 quarters
|
|
14
Cisco
CSCO
$377B
| $2.58M | 2.17% |
89,900
| – | – |
2013 Q2
12 quarters
|
|
15
AbbVie
ABBV
$521B
| $2.48M | 2.09% |
40,100
| – | – |
2013 Q2
12 quarters
|
|
16
Nucor
NUE
$56.6B
| $2.46M | 2.07% |
49,850
| – | – |
2013 Q2
12 quarters
|
|
17
Verizon
VZ
$192B
| $2.42M | 2.03% |
43,239
| – | – |
2013 Q2
12 quarters
|
|
18
ExxonMobil
XOM
$696B
| $2.23M | 1.87% |
23,799
| – | – |
2013 Q2
12 quarters
|
|
19
DELISTED
A T & T CORP (NEW)
T
| $2.14M | 1.8% |
49,540
| – | – |
2015 Q4
2 quarters
|
|
20
Marsh
MRSH
$98.8B
| $2.11M | 1.77% |
30,800
| – | – |
2013 Q2
12 quarters
|
|
21
Masco
MAS
$16.3B
| $2M | 1.68% |
64,800
| – | – |
2013 Q2
12 quarters
|
|
22
United Parcel Service
UPS
$95.7B
| $1.89M | 1.59% |
17,550
| – | – |
2013 Q2
12 quarters
|
|
23
Thermo Fisher Scientific
TMO
$259B
| $1.85M | 1.55% |
12,500
| – | – |
2013 Q2
12 quarters
|
|
24
DELISTED
EMC CORPORATION
EMC
| $1.79M | 1.51% |
66,000
| – | – |
2013 Q2
12 quarters
|
|
25
Coca-Cola
KO
$427B
| $1.7M | 1.43% |
37,600
| – | – |
2013 Q2
12 quarters
|
|
Similar funds
ECH
CCM
BNMT
Bonness Enterprises's Q2 2016 Portfolio in Review
As of Q2 2016, Bonness Enterprises held 47 positions worth $119M, up 2.4% from $116M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Trading was light in Q2 2016: portfolio turnover was 2.1%. Bonness Enterprises opened 1 new position and made no exits, leaving the 47-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Financials and Technology.
- Bonness Enterprises's largest Q2 2016 buy was BP: 6,846 shares worth $205K.
- Bonness Enterprises's biggest Q2 2016 reduction was Philips, cutting an estimated $47K.
- Bonness Enterprises's ten largest holdings make up 53% of its $119M portfolio in Q2 2016.
- Bonness Enterprises opened 1 new position and closed 0 in Q2 2016.
- Bonness Enterprises's portfolio value rose 2.4% quarter-over-quarter to $119M.
Based on Bonness Enterprises's 13F filing for Q2 2016, filed 12 Jul 2016.